BMC Pulmonary Medicine (Dec 2019)

PedCAPNETZ – prospective observational study on community acquired pneumonia in children and adolescents

  • Martin Wetzke,
  • Matthias Volkmar Kopp,
  • Jürgen Seidenberg,
  • Christian Vogelberg,
  • Tobias Ankermann,
  • Christine Happle,
  • Gesche Voigt,
  • Holger Köster,
  • Thomas Illig,
  • Christiane Lex,
  • Antje Schuster,
  • Marcus Panning,
  • Grit Barten,
  • Gernot Rohde,
  • Tobias Welte,
  • Gesine Hansen,
  • pedCAPNETZ Study Group

DOI
https://doi.org/10.1186/s12890-019-1013-5
Journal volume & issue
Vol. 19, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Background Pediatric community acquired pneumonia (pedCAP) is one of the leading causes for childhood morbidity accounting for up to 20% of pediatric hospital admissions in high income countries. In spite of its high morbidity, updated epidemiological and pathogen data after introduction of preventive vaccination and novel pathogen screening strategies are limited. Moreover, there is a need for validated recommendations on diagnostic and treatment regimens in pedCAP. Through collection of patient data and analysis of pathogen and host factors in a large sample of unselected pedCAP patients in Germany, we aim to address and substantially improve this situation. Methods pedCAPNETZ is an observational, multi-center study on pedCAP. Thus far, nine study centers in hospitals, outpatient clinics and practices have been initiated and more than 400 patients with radiologically confirmed pneumonia have been enrolled, aiming at a total of 1000 study participants. Employing an online data base, information on disease course, treatment as well as demographical and socioeconomical data is recorded. Patients are followed up until day 90 after enrollment; Comprehensive biosample collection and a central pedCAPNETZ biobank allow for in-depth analyses of pathogen and host factors. Standardized workflows to assure sample logistics and data management in more than fifteen future study centers have been established. Discussion Through comprehensive epidemiological, clinical and biological analyses, pedCAPNETZ fills an important gap in pediatric and infection research. To secure dissemination of the registry, we will raise clinical and scientific awareness at all levels. We aim at participating in decision making processes for guidelines and prevention strategies. Ultimately, we hope the results of the pedCAPNETZ registry will help to improve care and quality of life in pedCAP patients in the future.